CRANBURY, NJ -- (MARKET WIRE) -- November 08, 2006 -- Valera Pharmaceuticals (NASDAQ: VLRX), a specialty pharmaceutical company focused on the development, acquisition and commercialization of products for the urology and endocrinology markets, today reported results for the third quarter and nine months ended September 30, 2006.
